10x Genomics, Inc. (TXG)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.26
Street estimate
Revenue target
$147.2M
Street estimate
Trailing EPS (avg 4Q)
$-0.15
Beat rate last 4: 75%
Latest EPS YoY
-150.0%
vs 2025-08-07
Latest revenue YoY
-12.6%
How results look so far
Trailing revenue (avg 4Q)
$154.2M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS beat
EPS actual / est
$-0.14 / $-0.24
+42.4%
Revenue actual / est
$151.0M / $146.7M
+3.0%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.26 | Pending | — | $147.2M | Pending | — |
| 8/6/2026 | $-0.24 | $-0.14 | +42.4% | $146.7M | $151.0M | +3.0% |
| 5/14/2026upcoming | $-0.25 | Pending | — | $146.5M | Pending | — |
| 5/7/2026 | $-0.29 | $-0.10 | +65.5% | $146.4M | $150.8M | +3.0% |
| 2/12/2026 | $-0.19 | $-0.13 | +31.6% | $159.7M | $166.0M | +4.0% |
| 2/11/2026upcoming | $-0.20 | Pending | — | — | Pending | — |
| 11/6/2025 | $-0.07 | $-0.22 | -214.3% | $142.5M | $149.0M | +4.6% |
| 8/7/2025 | $-0.35 | $0.28 | +180.0% | $139.5M | $172.9M | +23.9% |
| 5/8/2025 | $-0.45 | $-0.36 | +20.0% | $145.3M | $154.9M | +6.6% |
| 2/12/2025 | $-0.29 | $-0.40 | -37.9% | $165.0M | $165.0M | +0.0% |
| 10/29/2024 | $-0.34 | $-0.30 | +11.8% | $153.3M | $151.7M | -1.1% |
| 8/8/2024 | $-0.47 | $-0.32 | +31.9% | $150.1M | $153.1M | +2.0% |
| 4/30/2024 | $-0.46 | $-0.50 | -8.7% | $142.2M | $141.0M | -0.9% |
| 2/15/2024 | $-0.36 | $-0.41 | -13.9% | $182.8M | $184.0M | +0.6% |
| 11/2/2023 | $-0.45 | $-0.51 | -13.3% | $151.3M | $153.6M | +1.5% |
| 8/3/2023 | $-0.39 | $-0.53 | -35.9% | $140.0M | $146.8M | +4.9% |
| 5/3/2023 | $-0.38 | $-0.44 | -15.8% | $138.8M | $134.3M | -3.2% |
| 2/15/2023 | $-0.29 | $-0.15 | +48.3% | $148.2M | $156.2M | +5.4% |
| 11/2/2022 | $-0.45 | $-0.37 | +17.8% | $129.0M | $131.1M | +1.6% |
| 8/8/2022 | $-0.40 | $-0.57 | -42.5% | $115.7M | $114.6M | -0.9% |
| 5/4/2022 | $-0.37 | $-0.38 | -2.7% | $113.2M | $114.5M | +1.1% |
| 2/16/2022 | $-0.06 | $-0.16 | -166.7% | $148.5M | $143.5M | -3.4% |
| 11/3/2021 | $-0.18 | $-0.15 | +16.7% | $146.2M | $125.3M | -14.3% |
| 8/4/2021 | $-0.26 | $-0.10 | +61.5% | $112.8M | $115.8M | +2.7% |
| 5/5/2021 | $-0.25 | $-0.11 | +56.0% | $151.7M | $105.8M | -30.2% |
| 2/17/2021 | $-0.28 | $-0.08 | +71.4% | $1.50B | $112.2M | -92.5% |
| 11/10/2020 | $-0.33 | $-0.33 | 0.0% | $66.7M | $71.8M | +7.7% |
| 8/11/2020 | $-0.59 | $-0.41 | +30.5% | $57.6M | $42.9M | -25.5% |
| 5/11/2020 | $-0.20 | $-0.22 | -10.0% | $54.8M | $71.9M | +31.3% |
| 2/18/2020 | $-0.15 | $-0.07 | +53.3% | $118.3M | $75.3M | -36.4% |
| 11/7/2019 | $-0.13 | $-0.33 | -153.8% | $45.9M | $61.2M | +33.3% |
| 9/11/2019 | — | $-0.25 | — | — | $53.6M | — |
| 6/30/2019 | — | $-0.70 | — | — | $55.8M | — |
| 12/31/2018 | — | $-5.39 | — | — | $50.6M | — |
| 9/30/2018 | — | $-1.13 | — | — | $36.6M | — |
| 6/30/2018 | — | $-0.46 | — | — | $31.7M | — |
| 3/31/2018 | — | $-0.83 | — | — | $29.6M | — |